Becton Dickinson Profit Margin 2006-2019 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of June 30, 2019 is 5.02%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $68.374B $15.983B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $25.548B 9.87
AmerisourceBergen (ABC) United States $17.487B 12.02
Align Technology (ALGN) United States $16.713B 45.59
Laboratory Of America Holdings (LH) United States $16.392B 15.52
Cooper (COO) United States $14.632B 24.76
Cardinal Health (CAH) United States $14.006B 9.07
Straumann Holding AG (SAUHF) Switzerland $13.281B 0.00
DENTSPLY SIRONA (XRAY) United States $12.048B 25.47
West Pharmaceutical Services (WST) United States $10.457B 45.45
Henry Schein (HSIC) United States $9.168B 16.32
CONMED (CNMD) United States $2.696B 41.07
Patterson (PDCO) United States $1.655B 12.28
Merit Medical Systems (MMSI) United States $1.606B 16.72
Atrion (ATRI) United States $1.458B 40.56
STAAR Surgical (STAA) United States $1.188B 70.16
Antares Pharma (ATRS) United States $0.548B 0.00
Invacare (IVC) United States $0.247B 0.00
Lifevantage (LFVN) United States $0.197B 23.61
Endologix (ELGX) United States $0.061B 0.00
Pro-Dex (PDEX) United States $0.054B 17.23
Milestone Scientific (MLSS) United States $0.047B 0.00
Retractable Technologies (RVP) United States $0.034B 0.00
Biolase (BIOL) United States $0.019B 0.00